Answers are grounded in this paper and cite their sources.
Randomized trial reveals a ketogenic diet promotes weight loss without reducing steatosis in NAFLD patients, suggesting limited impact on disease progression.
Background Despite the popularity of a ketogenic diet, no randomized, controlled trials have evaluated its efficacy on nonalcoholic fatty liver (NAFLD) progression. Methods We conducted 8-week, open-label randomized controlled trial involving 24 patients with NAFLD who were randomly assigned to either the home delivery ketogenic diet or general lifestyle advice counselling DASH diet. The primary outcome was reduction of hepatic steatosis as measured by transient elastography. Secondary outcome included metabolic profiles, and anthropometrics. Results There were no significant differences between groups in liver stiffness and steatosis measurement after dietary interventions. Subjects on a ketogenic diet had lost more weight than subjects in control group at 8 weeks (mean change [95% CI], -6.16 [-7.22, -5.10] vs. -2.14 [-4.49, 0.21] kg; P=0.001). The decrease in waist circumference, systolic blood pressure, fat mass and visceral fat area were significantly greater among subjects on a ketogenic diet than among those in control group. Laboratory parameters including AST, triglyceride and HDL were also significantly decreased among subjects on a ketogenic diet than among those in control group. Conclusions A ketogenic diet produced a significantly greater weight loss (absolute difference, approximately 4 percent) than did the general lifestyle advice intervention for the first 8 weeks. A ketogenic diet was associated with a greater improvement in some risk factors for coronary heart disease and NAFLD. However, a ketogenic diet did not reduce steatosis but not worsen NAFLD progression. Longer and larger studies are required to determine the long-term safety and efficacy of the ketogenic diet. First registration 26/04/2022, Clinical trial registration number: TCTR20220426005.
No takes yet. Share an insight, caveat, or question.
Chirapongsathorn et al. (2023) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: